Navigation Links
Accumed Research Associates Featured On Katz's Corner 77 WABC Radio Show To Discuss Enlarged Prostate Treatment and Clinical Trials In Urology
Date:1/13/2014

Garden City, New York (PRWEB) January 13, 2014

Mitchell Efros MD FACS, President and Medical Director of Accumed Research Associates appeared on Katz's Corner News Talk Radio 77 WABC to discuss clinical research as an option for medical care. Visit Katz's Corner Accumed Research January 14, 2014 and listen to the January 12th, 2014 podcast to hear the entire broadcast.

Accumed Research Associates offers enlarged prostate (BPH) treatment for men that experience symptoms. The various clinical trials may provide novel therapeutic alternatives for men suffering with urinary problems referred to as lower urinary tract symptoms (LUTS). The clinical trials offered are for men who are naive to treatment and those that have tried other therapies other than surgery before. Accumed Research Associates provides enlarged prostate (BPH) treatment on Long Island, New York.

Accumed Research Associates also conducts clinical trials for men with low testosterone, prostate cancer, men and women with overactive bladder and urinary incontinence or frequent urination, as well as healthy volunteer studies. Dr. Efros reviewed the steps necessary to participate in a clinical trial and how clinical trials advance medical therapy and bring potential added value to the patient.

Dr. Mitchell Efros MD FACS, Medical Director and President of Accumed Research Associates stated, "Clinical trials provide alternatives to the standard forms of therapy that are currently available."

About Accumed Research Associates:
Accumed Research Associates has been providing expert urologic care for over 14 years by a board certified urologist and seasoned compassionate healthcare providers. Located in Garden City, New York Accumed Research Associates provides alternatives and cutting edge medication and technology. Contact Accumed Research Associates at 1 (888) 746-2190 or visit us and register on our website at http://www.accumedresearch.com.

Read the full story at http://www.prweb.com/releases/AccumedResearchNewsTalk/RadioShowClinicalTrials/prweb11482440.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Penn research helps lay out theory for metamaterials that act as an analog computer
2. Louisiana’s First Clinical Data Research Network to Be Developed Through PCORI Funding
3. Capsugel’s Bend Research to Present New Processes for Flu Vaccine and Other Science Advancements at Upcoming Industry Meetings
4. New Insights on the Decline of Research and Development in Pharma & Biotech
5. New Jersey Health Foundation President Addresses Panel at AAHC Research Efficiency Conference
6. Cardio3 BioSciences, a European biopharmaceutical company, now covered by Edison Investment Research
7. Nanomedicine Market is Expected to Reach USD 177.60 Billion Globally in 2019: Transparency Market Research
8. Elsevier Launches the New Generation SciVal, Providing Dynamic Real-Time Analytics and Insights into the Global Research Landscape
9. Paraformaldehyde Industry 2014 Global & China Development Analysis in a New Research Study Available at DeepResearchReports.com
10. Researchers find that computer components can be damaged by key manufacturing processes
11. PCCI Collaborates With UTSW On Top National Research Grants Totaling Over $30 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Jan 19, 2017 Research and Markets ... has announced the addition of the ... - Forecast to 2025" report to their offering. ... The report provides a detailed analysis on current and future market ... 2025, using estimated market values as the base numbers ...
(Date:1/19/2017)... AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: AQB), ... and a majority-owned subsidiary of Intrexon Corporation (NYSE: ... listing of its common shares on the NASDAQ Stock ... "AquaBounty,s listing on NASDAQ represents an important milestone ... the U.S. markets as we advance plans for commercial ...
(Date:1/19/2017)... NEW YORK , Jan. 18, 2017 /PRNewswire/ ... expected to reach USD 92.9 billion by 2025, ... Research, Inc. Pharmaceutical industry has been adaptive of ... functions as early as 2002. Among the services ... the forerunners. For instance, Johnson & Johnson was ...
(Date:1/18/2017)... , January 18, 2017 According to a new market ... Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic and Research ... to reach USD 739.9 Million by 2021 from USD 557.1 Million in 2016, ... ... MarketsandMarkets Logo ...
Breaking Biology Technology:
(Date:12/22/2016)... SuperCom (NASDAQ:   SPCB ... e-Government, Public Safety, HealthCare, and Finance sectors announced today that Leaders ... to implement and deploy a community-based supportive services program to reduce ... , further expanding its presence in the state. ... This new program, which is expected ...
(Date:12/16/2016)... DUBLIN , Dec 16, 2016 Research ... Access System Market - Global Forecast to 2021" report to ... ... projected to grow at a CAGR of 14.06% from 2016 to ... 2016, and is projected to reach 854.8 Million by 2021. The ...
(Date:12/15/2016)... 2016 Advancements in biometrics will ... and wellbeing (HWW), and security of vehicles ... passenger vehicles begin to feature fingerprint recognition, ... beat monitoring, brain wave monitoring, stress detection, ... pulse detection. These will be driven by ...
Breaking Biology News(10 mins):